Skip to main content
Search
Explore journals
Get published
About BMC
My account
Search all BMC articles
Search
BMC Cancer
Home
About
Articles
Submission Guidelines
Collections
Join the Board
Submit manuscript
Article metrics
Last updated: Wed, 25 Sep 2024 14:10:52 Z
Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical practice
